Agents and Actions

, Volume 13, Issue 5–6, pp 398–405 | Cite as

Receptors for complement components in inflammation

  • A. Sobel
  • C. Blanc
  • A. Cattaneo
  • Monique Moisy
  • Margarita Lopez-Trascasa
  • J. -J. Bourgarit
  • Yvette Gabay
The Complement System: Formation, Activation and Modes of Action

Keywords

Complement Component 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    R.A. Nelson,The immune-adherence phenomenon. An immunologically specific reaction between micro-organisms and erythrocytes leading to enhanced phagocytosis, Science, N.Y.118, 733–734 (1953).Google Scholar
  2. [2]
    W.H. Lay andV. Nussenzweig,Receptors for complement on leukocytes, J. exp. Med.128, 991–1003 (1968).Google Scholar
  3. [3]
    G.D. Ross,Analysis of the different types of leukocyte membrane complement receptors and their interaction with the complement system, J. Immunol. Methods37, 197–211 (1980).Google Scholar
  4. [4]
    T.F. Tedder, D.T. Fearon, G.L. Gartland andM.D. Cooper,Expression of complement receptor type one (for C3b) on human natural killer cells, B cells and lymphoblastoid cell lines, IX International Complement Workshop, Key Biscayne, USA, 1981.Google Scholar
  5. [5]
    D.T. Fearon,Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leucocyte, B-lymphocyte and monocyte. J. exp. Med.152, 20–32 (1980).Google Scholar
  6. [6]
    D.T. Fearon, I. Kaneko andG.G. Thomson,Membrane distribution and adsorptive endocytosis by C3b receptors on polymorphonuclear leukocytes, J. exp. Med.153, 1615–1628 (1981).Google Scholar
  7. [7]
    M.P. Dierich, H.H. Mussel, O. Scheiner, T. Ehlen, R. Burger, M. Peters, M. Schmitt, S. Trepke andG. Zimmer,Differentiation of C3b receptors on human lymphocytes, phagocytes, erythrocytes and renal glomerulus cells by monoclonal antibodies, Immunology45, 85–96 (1982).Google Scholar
  8. [8]
    K. Whaley,Biosynthesis of the complement components and the regulatory proteins of the alternative pathway by human peripheral blood monocytes, J. exp. Med.151, 501–512 (1980).Google Scholar
  9. [9]
    J.D. Lambris, N.J. Dobson andG.D. Ross,Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for β1H globulin, J. exp. Med.152, 1625–1644 (1980).Google Scholar
  10. [10]
    R.D. Schreiber andM.J. Muller-Eberhard,Fourth component of human complement: description of a three polypeptide chain structure, J. exp. Med.140, 1324–1335 (1974).Google Scholar
  11. [11]
    N.R. Cooper,Immune adherence by the fourth component of complement, Science, N.Y.165, 396–398 (1969).Google Scholar
  12. [12]
    V.A. Bokisch andA.T. Sobel,Receptor for the fourth component of complement on human B-lymphocytes and cultured lymphoblastoid cells, J. exp. Med.140, 1336–1347 (1974).Google Scholar
  13. [13]
    G.D. Ross andM.J. Polley,Specificity of human lymphocyte complement receptors, J. exp. Med.141, 1163–1180 (1975).Google Scholar
  14. [14]
    G.D. Ross andM.J. Polley,Human lymphocyte and granulocyte receptors for the fourth component of complement (C4) and the role of granulocyte receptors in phagocytosis, Fed. Proc.33, 759 (abs.) (1974).Google Scholar
  15. [15]
    C. Blanc, M. Lopez-Trascasa andA.T. Sobel,C4 dependent phagocytosis by human mononuclear cells, V European Complement Workshop, Lund, 1980.Google Scholar
  16. [16]
    K. Iida andV. Nussenzweig,Complement receptor is an inhibitor of the complement cascade, J. exp. Med.153, 1138–1149 (1981).Google Scholar
  17. [17]
    B. Landen andM.P. Dierich,Identity of C3 and C5 receptors on lymphoid cells, J. Immun.122, 1015–1017 (1979).Google Scholar
  18. [18]
    A.G. Ehlenberger andV. Nussenzweig,The role of membrane receptors for C3b and C3d in phagocytosis, J. exp. Med.145, 357–371 (1977).Google Scholar
  19. [19]
    J.D. Lambris, N.J. Dobson andG.D. Ross,Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor specific antibody, Proc. natl Acad. Sci. USA78, 1828–1832 (1981).Google Scholar
  20. [20]
    G.D. Ross andJ.D. Lambris,Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils and erythrocytes, J. exp. Med.155, 96–110 (1982).Google Scholar
  21. [21]
    G. Vranian Jr, D.H. Conrad andS. Ruddy,Specificity of C3 receptors that mediate phagocytosis by rat peritoneal mast cells, J. Immun.126, 2302 (1981).Google Scholar
  22. [22]
    I.R. Carlo, D.H. Conrad andS. Ruddy,Binding of C3b-coated erythrocytes to the human glomerular complement receptor before and after treatment with C3b inactivator, β1H globulin and trypsin, Fedn Proc.37, 1477 (1978).Google Scholar
  23. [23]
    M. Schmitt, H.H. Mussel, K.P. Hammann, O. Scheiner andM.P. Dierich,Role of β1H for the binding of C3b coated particles to human lymphoid and phagocytic cells, Eur. J. Immunol.11, 739–745 (1981).Google Scholar
  24. [24]
    G.D. Ross andJ.D. Lambris,Identification of three forms of iC3b that have distinct structures and receptor binding site properties, IX International Complement Workshop, Key Biscane, USA, 1981.Google Scholar
  25. [25]
    J.D. Lambris, N.J. Dobson, M. Dozier andG.D. Ross,Antibody to the idiotype of anti β1H has specificity for B lymphocyte membrane β1H receptors and C3b, Fedn Proc.40, 1013 (1981).Google Scholar
  26. [26]
    A.T. Sobel andV.A. Bokisch, Receptors for C4b and C1q on human peripheral lymphocytes and lymphoblastoid cells. InMembrane Receptors of Lymphocytes, pp. 151–158 (Eds.M. Seligmann, J.L. Preud'homme andK.M. Kourilsky). Elsevier, New York, 1975.Google Scholar
  27. [27]
    A.T. Sobel, Y. Gabay andG. Lagrue,Further studies of C1q binding to human and mouse lymphocytes, Path. Biol.25, 403 (1977).Google Scholar
  28. [28]
    Y. Gabay, H. Perlmann, P. Perlmann andA.T. Sobel,A rosette assay for the determination of C1q receptor bearing cells, Eur. J. Immunol.9, 797–800 (1979).Google Scholar
  29. [29]
    A.J. Tenner andN.R. Cooper,Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells, J. Immun.125, 1658–1663 (1980).Google Scholar
  30. [30]
    A.J. Tenner andN.R. Cooper,Identification of types of cells in human peripheral blood that bind C1q, J. Immun.126, 1174–1179 (1981).Google Scholar
  31. [31]
    R.J. Ziccardi andN.R. Cooper, Active disassembly of the first complement component\(C\bar 1\) by\(C\bar 1\) inactivator, J. Immun.123, 788–792 (1979).Google Scholar
  32. [32]
    R.B. Sim, G.J. Arlaud andM.G. Colomb,\(C\bar 1\) inhibitors dependent dissociation of human complement component\(C\bar 1\) bound to immune complexes, Biochem. J.179, 449–456 (1979).Google Scholar
  33. [33]
    J.L. Wautier, H. Souchon, Cohen-Solal, A.P. Peltier andJ.P. Caen,C1 and human platelets; role of C1 subcomponents in platelets aggregation induced by aggregated IgG, Immunology31, 595–599 (1976).Google Scholar
  34. [34]
    N.R. Cooper, F.C. Jensen, R.M. Welsh andM.B.A. Oldstone,Lysis of RNA tumor viruses by human serum: direct antibody independent triggering of the classical complement pathway, J. exp. Med.144, 970–982 (1976).Google Scholar
  35. [35]
    T.E. Hugli andM.J. Muller-Eberhard,Anaphylatoxins: C3a and C5a, Adv. Immunol.26, 1–53 (1978).Google Scholar
  36. [36]
    E.L. Morgan, W.O. Weigle andT.E. Hugli,Are the anaphylatoxins immunoregulatory factors? IX International complement Workshop, Key Biscayne, USA, 1981.Google Scholar
  37. [37]
    C. Gerard andT.E. Hugli,Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des Arg 74 C5a, Proc. natn. Acad. Sci. USA78, 1833–1837 (1981).Google Scholar
  38. [38]
    J.P. Gorski, T.E. Hugli andH.J. Muller-Eberhard,C4a: the third anaphylatoxin of the human complement system, Proc. natn. Acad. Sci. USA76, 5299–5302 (1979).Google Scholar
  39. [39]
    M.M. Glovsky, T.E. Hugli, T. Ishizaka, L.M. Lichtenstein andB.W. Erikson,Anaphylatoxin induced histamine release with human leukocytes. Studies of C3a leukocyte binding and histamine release, J. clin. Invest.64, 804–811 (1979).Google Scholar
  40. [40]
    J.W. Goers andM.M. Glovsky,C3a binding to human leukocytes, J. Immun.124, 1522 (abs.) (1980).Google Scholar
  41. [41]
    K. Rother,Leukocyte mobilizing factor: a new biological activity from the third component of complement, Eur. J. Immunol.2, 550–553 (1972).Google Scholar
  42. [42]
    B. Ghebrehiwet andH.J. Muller-Eberhard,C3e: an acidic fragment of human C3 with leukocytosis inducing activity, J. Immun.123, 616–621 (1979).Google Scholar
  43. [43]
    M. Lopez-Trascasa, M. Moisy, E. Pirotzky, Y. Blouquit, C. Blanc andA.T. Sobel,Isolation and characterization of a biologically active C2 derived oligopeptide, IX International Complement Workshop, Key Biscayne, USA, 1981.Google Scholar
  44. [44]
    H. Huber, M.J. Polley, W.D. Linscott, H.H. Fudenberg andH.J. Muller-Eberhard,Human monocytes: distinct receptors for the third component of complement and for immunoglobulin G, Science, N.Y.162, 1281–1283 (1968).Google Scholar
  45. [45]
    R.D. Schreiber, A.B. Bjornson andM.K. Pangburn,The role of C3 fragments in polymorphonuclear leukocyte (PMN) mediated cytocidal reactions, IX International Complement Workshop, Key Biscayne, USA, 1981.Google Scholar
  46. [46]
    J.P. Atkinson andM.M. Frank,Studies on the in vivo effects of antibody: interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man, J. clin. Invest.54, 339–348 (1974).Google Scholar
  47. [47]
    C.M. Lockwood, S. Worlledge, A. Nicholas, C. Cotton andD.K. Peters,Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange, New Engl. J. Med.300, 524–530 (1979).Google Scholar
  48. [48]
    F.M. Griffin,Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated cryptococcus neoformans, Proc. natn. Acad. Sci. USA78, 3853–3857 (1981).Google Scholar
  49. [49]
    A.D. Schreiber, J. Parsons, P. McDermott andR.A. Cooper,Effects of corticosteroids on the human monocyte IgG and complement receptors, J. clin. Invest.56, 1189–1197 (1975).Google Scholar
  50. [59]
    H.U. Schorlemmer, P. Davies andA.C. Allison,Ability of activated complement components to induce lysosomal enzyme release from macrophages, Nature, Lond.261, 48–49 (1976).Google Scholar
  51. [51]
    O. Gotze, C. Bianco andZ.A. Cohn,The induction of macrophage spreading by factor B of the properdin system, J. exp. Med.149, 372–386 (1979).Google Scholar
  52. [52]
    S.M. Wahl, G.M. Iverson andJ.J. Oppenheim,Induction of guinea pig B cell lymphokine synthesis by mitogenic and non mitogenic signals to Fc, Ig and C3 receptors, J. exp. Med.140, 1631–1645 (1974).Google Scholar
  53. [53]
    A.L. Sandberg, S.M. Wahl andS.E. Mergenhagen,Lymphokine production by C3b-stimulated B cells, J. Immun.115, 139–144 (1975).Google Scholar
  54. [54]
    P. Perlmann, H. Perlmann andH.J. Muller-Eberhard,Cytotoxic effects of leukocytes triggered by complement bound to target cells, Science, N.Y.163, 937–939 (1969).Google Scholar
  55. [55]
    B. Ghebrehiwet andH.J. Muller-Eberhard,Lysis of C1q-coated chicken erythrocytes by human lymphoblastoid cell lines, J. Immun.120, 27–30 (1978).Google Scholar
  56. [56]
    B. Ghebrehiwet, R.G. Medicus andH.J. Muller-Eberhard,Potentiation of antibody-dependent cell-mediated cytotoxicity by target cell-bound C3b, J. Immun.123, 1285–1288 (1979).Google Scholar
  57. [57]
    H. Perlmann, P. Perlmann, R.D. Schreiber andH.J. Muller-Eberhard,Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors, J. exp. Med.153, 1592–1603 (1981).Google Scholar
  58. [58]
    V. Nussenzweig, Interaction between complement and immune complexes: role of complement in containing immune complex damage. InProgress in Immunology, vol. IV, pp. 1044–1056 (Eds.M. Fougereau andJ. Dausset). Academic Press, London 1980.Google Scholar
  59. [59]
    M.C. Gelfand, M.M. Frank andI. Green,A receptor for the third component of complement in the human renal glomerulus, J. exp. Med.142, 1029–1034 (1975).Google Scholar
  60. [60]
    M.D. Kazatchkine, D.T. Fearon, M.D. Appay, C. Mandet andJ. Bariety,Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in renal diseases: loss of C3b receptor antigen in proliferative nephritis of SLE, IX International Complement Workshop, Key Biscayne, USA, 1981.Google Scholar
  61. [61]
    A. Sobel, Y. Gabay andG. Lagrue,Analysis of glomerular complement receptors in various types of glomerulonephritis, Clin. Immunol. Immunopathol.6, 94–101 (1976).Google Scholar
  62. [62]
    D.B. Cines, A.P. Lyss, M. Bina, R. Lorkey, N.A. Kefalides andH.M. Friedman,Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells, J. clin. invest.69, 123–128 (1982).Google Scholar

Copyright information

© Birkhäuser Verlag 1983

Authors and Affiliations

  • A. Sobel
    • 1
  • C. Blanc
    • 1
  • A. Cattaneo
    • 1
  • Monique Moisy
    • 1
  • Margarita Lopez-Trascasa
    • 1
  • J. -J. Bourgarit
    • 1
  • Yvette Gabay
    • 1
  1. 1.INSERM U 139Hôpital Henri MondorCreteilFrance

Personalised recommendations